导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 11.67% | 295/1050 |
| 近一周 | -0.11% | 305/1104 |
| 近一月 | -6.60% | 922/1103 |
| 近一季 | -7.44% | 591/1092 |
| 近半年 | 1.79% | 401/1070 |
| 近一年 | 11.98% | 342/1018 |
| 近两年 | 101.78% | 197/926 |
| 近三年 | 47.98% | 281/834 |
| 成立以来 | 337.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.31% 401/1070 |
32.35% 303/1101 |
- - |
- - |
| 2025 | 34.58% 406/1065 |
16.36% 40/1014 |
-1.02% 768/1038 |
24.19% 467/1050 |
-5.91% 734/1065 |
| 2024 | 1.97% 527/1011 |
-13.32% 869/960 |
-3.19% 518/983 |
16.82% 146/991 |
4.02% 163/1011 |
| 2023 | 3.66% 51/952 |
14.06% 58/880 |
-1.48% 262/895 |
-5.11% 317/915 |
-2.79% 304/952 |
| 2022 | -34.17% 700/867 |
-25.05% 716/773 |
7.50% 375/806 |
-15.36% 585/845 |
-3.46% 595/867 |
| 2021 | 26.15% 102/740 |
-12.57% 536/580 |
29.81% 53/659 |
-2.13% 261/704 |
13.57% 35/740 |
| 2020 | 70.41% 143/554 |
3.71% 87/419 |
21.98% 251/466 |
11.92% 203/517 |
20.37% 114/554 |
| 2019 | 56.97% 97/410 |
21.43% 889/1146 |
2.23% 153/1228 |
13.09% 67/390 |
11.80% 115/410 |
| 2018 | -20.97% 94/349 |
- - |
-11.34% 567/990 |
-8.46% 675/1000 |
-7.24% 115/1080 |
| 2017 | 33.45% 27/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 景顺长城环保优势股票 VS. 东吴新产业精选股票A(580008) |